Get the Stockscreener App
7.46
4.78%
0.34
After Hours:
7.45
-0.010
-0.13%
Nyxoah Sa stock is traded at $7.46, with a volume of 94,628.
It is up +4.78% in the last 24 hours and down -0.27% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$7.12
Open:
$7.56
24h Volume:
94,628
Relative Volume:
1.23
Market Cap:
$266.54M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-4.4426
EPS:
-1.6792
Net Cash Flow:
$-60.34M
1W Performance:
-4.24%
1M Performance:
-0.27%
6M Performance:
-30.93%
1Y Performance:
-10.77%
1-Day Range:
$7.22
$7.565
1-Week Range:
$7.00
$7.77
52-Week Range:
$5.55
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
7.46 | 266.54M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
How Nyxoah SA stock performs during market volatilityReal Chart Based Opportunity Identification - Newser
Nyxoah SA stock daily chart insightsWeekly Portfolio Update with ROI Focus - Newser
New Product Launches: Will They Boost Nyxoah SA Stock in 2025Stock Forecast Tools for Retail Traders - Newser
Moving Average Trends for Nyxoah SA Stock: What They IndicateReal Time Stock Movement and Alerts - Newser
Is Nyxoah SA Stock a Good Fit for Conservative InvestorsTarget Return Focused Trade Insights Shared - metal.it
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 - The Manila Times
Information on the total number of voting rights and shares - Yahoo.co
Nyxoah Earnings: Sleep Apnea Tech Leader Sets Q2 2025 Financial Report Date - Stock Titan
Nyxoah stock rises on positive DREAM study data publication - Investing.com
Nyxoah stock rises on positive DREAM study data publication By Investing.com - Investing.com South Africa
How Interest Rate Changes Impact Nyxoah SA Stock PerformancePrice Action Trading with Volume Confirmation - Newser
When is the best time to buy Nyxoah SA stockFree Capital Preserving Trade Plan Templates - Newser
Trapped Investors in Nyxoah SA Await Breakout SignalWeekly Stock Watch With Growth Focus Expanded - metal.it
Nyxoah publishes DREAM study data in Journal of Clinical Sleep Medicine - TipRanks
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine - The Manila Times
Breakthrough Sleep Apnea Treatment: New Clinical Data Shows 84% of Patients Using Nyxoah's Device Consistently - Stock Titan
Bullish Divergence Spotted in Nyxoah SA MomentumOversold Bounce Stock Play Ideas Gain Attention - metal.it
Is it the right time to buy Nyxoah SA stockMaximize your portfolio’s growth potential - jammulinksnews.com
Nyxoah stock holds Buy rating at Stifel following DREAM publication By Investing.com - Investing.com South Africa
Does Nyxoah SA stock perform well during market downturnsFree Stock Market Real-Time Monitoring - jammulinksnews.com
What are the technical indicators suggesting about Nyxoah SAHigh-margin investment plays - jammulinksnews.com
How strong is Nyxoah SA company’s balance sheetFree Stock Market Knowledge Sharing - jammulinksnews.com
How does Nyxoah SA compare to its industry peersCapitalize on market trends with confidence - jammulinksnews.com
Has Nyxoah SA Stock Ever Crashed Historical Volatility ReviewFree Access to Investors Club - Newser
Does Nyxoah SA stock pay reliable dividendsOutstanding capital returns - jammulinksnews.com
Nyxoah SA Stock Analysis and ForecastRecord-setting profit potential - Autocar Professional
What analysts say about Nyxoah SA stockHigh-yield market plays - Autocar Professional
Is Nyxoah SA stock overhyped or has real potentialExceptional gains - jammulinksnews.com
Is Nyxoah SA a good long term investmentTriple-digit growth rates - Autocar Professional
What drives Nyxoah SA stock priceConsistently exceptional gains - jammulinksnews.com
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):